Apparatus and method for detection of atrial fibrillation by ventricular stability and ventricular pacing

• US 5,591,215 A
• Filed: 11/17/1995
• Issued: 01/07/1997
• Est. Priority Date: 11/30/1994
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Telectronics Pacing Systems, Inc (Abbott Laboratories Incorporated)
• Inventors: Murphy, Anthony, Greenhut, Saul E.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): EVANISKO, GEORGE ROBERT
• Application Number:
  US08/560,447
• Time in Patent Office: 417 Days
• Field of Search: 607/4, 607/9, 607/14, 607/25, 128/702, 128/705
• US Class Current: 607/14
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance

Abstract

A cardiac implant device is provided in which the ventricular rate is monitored to differentiate between atrial fibrillation and ventricular tachycardia or other cardiac conditions. For this purpose, the ventricular rate stability is monitored by, for example, measuring the R-R intervals of successive ventricular beats. If the ventricular rate is found to be unstable, the ventricle is paced at a test rate to try to stabilize the ventricle. If the attempt is unsuccessful, atrial fibrillation is assumed and, if necessary, corresponding therapy is applied. If the attempt is unsuccessful, atrial fibrillation is eliminated as a cause of the ventricular rate instability and other types of classifying and treating the cardiac condition may be used.

Claims

1. An implantable cardiac device for stimulating a heart, said pacemaker comprising:

means for monitoring a ventricle of said heart to sense ventricular rate instability; and

means for pacing said ventricle;

wherein said means for monitoring detects atrial fibrillation based on a response of said ventricle to said ventricular pacing.

2. An implantable cardiac device comprising:

means for applying pacing signals to a ventricle in a patient'"'"'s heart;

means for sensing intrinsic ventricular signals in the ventricle;

means for determining ventricular rate instability based on said ventricular signals;

means for controlling said pacing signals; and

classifying means for classifying said ventricular instability as corresponding to one of atrial fibrillation and ventricular tachycardia from a response to said pacing signals.

3. A cardiac implant device comprising:

sensing means for sensing cardiac activity in a patient'"'"'s heart;

pacing means for generating cardiac pacing pulses; and

control means for controlling said pacing means in accordance with said cardiac activity, said control means including cardiac classifying means for classifying a cardiac condition of the patient'"'"'s heart, said cardiac classifying means including means for monitoring a ventricle to sense a ventricular rate instability;

said control means being provided to pace said ventricle at a rate selected to stabilize said ventricle, said classifying means classifying said cardiac condition as atrial fibrillation, if said pace stabilizes said ventricle.

4. The device of claim 3 wherein said classifying means further includes means for confirming said atrial fibrillation.

5. The device of claim 3 wherein said device further includes therapy application means for applying therapy after said atrial fibrillation condition has been identified.

6. A cardiac implant device comprising:

means for monitoring a ventricle to detect ventricular instability;

means for selectively pacing said ventricle to attempt to reduce said ventricular instability; and

means for classifying a cardiac condition based on a response to said pacing, said means for classifying generating information indicative of atrial fibrillation if said ventricular instability is reduced by said pacing.

7. The device of claim 6 wherein said pacing is successful if said ventricular instability is reduced by a predetermined amount.

8. The device of claim 6 further comprising means for providing antitachycardia therapy to the patient'"'"'s heart if said ventricular instability is not reduced by said pacing.

9. The device of claim 6 further comprising determining means for determining quantitatively said ventricular instability.

10. The device of claim 9 wherein each cardiac activity includes an R-wave, and said determining means includes means for measuring R-R intervals between successive R-waves.

11. The device of claim 10 wherein said determining means includes averaging means for taking an average of a plurality of R-R intervals.

12. The device of claim 6 further comprising confirming means for confirming atrial fibrillation after ventricular pacing by measuring a ventricular instability of the intrinsic ventricular rate.

13. An implantable cardiac device comprising:

means for applying pacing signals to a ventricle in a patient'"'"'s heart;

means for sensing intrinsic ventricular signals in the ventricle;

means for determining ventricular rate instability based on said ventricular signals;

means for controlling said pacing signals; and

classifying means for classifying said ventricular instability as corresponding to one of atrial fibrillation and supraventricular tachycardia from a response to said pacing signals.

14. A method of classifying the condition of a patient'"'"'s heart comprising:

monitoring intrinsic cardiac pulses in a ventricle to provide a signal indicative of ventricular rate stability;

if the ventricular rate is unstable, attempting to stabilize said ventricular rate by pacing the ventricle at a test pacing rate;

if pacing at said test pacing rate stabilizes the ventricular rate, then classifying the condition of the heart as atrial fibrillation.

15. The method of claim 14 wherein said step of monitoring includes:

measuring intervals between a preselected number of successive intrinsic cardiac pulses;

determining a ventricular rate from said measurements; and

comparing said ventricular rate to a preselected threshold.

16. The method of claim 15 after said comparing step further comprising the steps of:

determining if said ventricular rate is stable if said ventricular rate is within a preselected range;

if said ventricular rate is not stable, pacing said ventricle at said test pacing rate, said test pacing rate being related to said ventricular rate.

17. The method of claim 16 further comprising gradually reducing said test pacing rate until a preselected level is reached.

18. The method of claim 15 wherein said step of measuring intervals comprises measuring R-R intervals.

19. The method of claim 15 wherein said step of measuring intervals comprises monitoring successive R-R intervals and measuring excisions of each R-R interval from an average to determine a ventricular instability.